Preparation method of liposome based on drug-phospholipid-cholesterol ternary complex
A ternary compound and cholesterol technology, which is applied in the direction of liposome delivery, pharmaceutical formulations, medical preparations of non-active ingredients, etc., can solve the problems of unsuitability for industrialization, low production efficiency, high production cost, etc., and achieve easy industrial scale-up , reduced usage, high production efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0032] The method for preparing liposomes based on the drug-phospholipid-cholesterol ternary complex specifically implemented in the present invention includes:
[0033] The first step is to divide the prescription amount of phospholipids into the first amount of phospholipids and the second amount of phospholipids, the first amount is less than the second amount; take the target drug, the first amount of phospholipids and cholesterol into a container, and add a reaction solvent to make the material Dissolve completely, keep stirring at 30℃-80℃ for 1-8h, and then evaporate to remove the reaction solvent. The resulting product is placed in a vacuum for 8-16h to obtain a powdery solid or sponge-like semi-solid Drug-phospholipid-cholesterol ternary complex; the mass of the first amount of phospholipid is at least 3 times the mass of the target drug, and the mass ratio of the target drug to cholesterol is 1: (0.1-10); the amount of reaction solvent used is enough to 1-1.5 times the m...
Embodiment 1
[0041] The mass volume concentration (g / ml) of each component in the prescription is:
[0042] Baicalein 0.8%
[0043] Egg yolk lecithin 16.08%
[0044] Cholesterol 1.36%
[0045] The balance is pure water.
[0046] Preparation process: According to the above prescription, weigh baicalein, cholesterol and 3 times the mass of baicalein's egg yolk lecithin (that is, the mass ratio of baicalein to the first amount of egg yolk lecithin is 1:3, and the mass ratio of baicalein to cholesterol is 1:1.7), placed in an eggplant-shaped bottle, using tetrahydrofuran as the reaction solvent to completely dissolve the three, and after stirring at 30°C for 1 hour, the solvent was removed by evaporation, and the resulting product was kept under vacuum for 12 hours to obtain baicalein-egg yolk lecithin- Cholesterol ternary complex, take out, protect from light, and store in a cool place. The essence of this step is to prepare a ternary complex of baicalein-egg yolk lecithin-cholesterol by the solvent...
Embodiment 2
[0050] The mass volume concentration (g / ml) of each component in the prescription is:
[0051] Quercetin 0.2%
[0052] Egg yolk lecithin 4.49%
[0053] Cholesterol 0.4%
[0054] The balance is pure water.
[0055] Preparation process: According to the above prescription, weigh quercetin, cholesterol and egg yolk lecithin with 3.2 times the mass of quercetin (that is, the mass ratio of quercetin to the first amount of egg yolk lecithin is 1:3.2, quercetin and cholesterol The mass ratio is 1:2), placed in an eggplant-shaped bottle, using tetrahydrofuran as the reaction solvent to completely dissolve the three, and after stirring at 55°C for 4 hours, the solvent is evaporated and the resulting product is kept under vacuum for 12 hours to obtain quercetin -Egg yolk lecithin-cholesterol ternary complex, take it out, avoid light, and store in a cool place.
[0056] Weigh the remaining egg yolk lecithin in the prescription (that is, the second amount of egg yolk lecithin, the mass of the seco...
PUM
Property | Measurement | Unit |
---|---|---|
pore size | aaaaa | aaaaa |
particle diameter | aaaaa | aaaaa |
particle diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com